While drugs are available that reduce levels of lipoprotein (a), a protein associated with cardiovascular disease, no currently available therapies target this protein directly. Several companies are ...
CHICAGO (Reuters) -Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard therapies cut the risk of disease progression or death ...
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds
British pharmaceutical company AstraZeneca's manufacturing site in Macclesfield, northwest England. 2014 File Photo / Agence France-Presse CHICAGO — Treating breast cancer patients with AstraZeneca’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback